LC
PAHC icon

Lindbrook Capital’s Phibro Animal Health PAHC Stock Holding History

Lindbrook Capital’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$769 Hold
36
– – ﹤0.01% 2525
2024
Q4 		$756 Hold
36
– – ﹤0.01% 2533
2024
Q3 		$811 Sell
36
-36
-50% -$695 ﹤0.01% 2552
2024
Q2 		$1.21K Buy
+72
New +$1.16K ﹤0.01% 2458
2022
Q3 		– Sell
-12
Closed -$207 – 2835
2022
Q2 		$0 Sell
12
-105
-90% -$1.99K ﹤0.01% 2690
2022
Q1 		$2K Buy
+117
New +$2.36K ﹤0.01% 2048
2020
Q4 		– Sell
-240
Closed -$4K – 1846
2020
Q3 		$4K Sell
240
-130
-35% -$2.77K ﹤0.01% 1192
2020
Q2 		$10K Hold
370
– – ﹤0.01% 833
2020
Q1 		$9K Buy
370
+240
+185% +$5.87K ﹤0.01% 795
2019
Q4 		$3K Hold
130
– – ﹤0.01% 1229
2019
Q3 		$3K Hold
130
– – ﹤0.01% 1200
2019
Q2 		$4K Hold
130
– – ﹤0.01% 1115
2019
Q1 		$4K Hold
130
– – ﹤0.01% 1131
2018
Q4 		$4K Buy
+130
New +$4.91K ﹤0.01% 1076

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Lindbrook Capital's PAHC Position: Q1 2025 in Review

Lindbrook Capital held its Phibro Animal Health (PAHC) position steady in Q1 2025 at 36 shares worth $769. The position accounts for ﹤0.01% of the portfolio, ranked #2525.

Lindbrook Capital first reported a position in PAHC in Q4 2018 and has held it in 14 quarters since. The position peaked at $10K in Q2 2020. 182 funds tracked by Wall St. Rank hold PAHC as of Q1 2025.

  • Lindbrook Capital held 36 shares of Phibro Animal Health worth $769 as of Q1 2025.
  • Lindbrook Capital left its Phibro Animal Health share count unchanged in Q1 2025.
  • Phibro Animal Health made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2525 holding.
  • Lindbrook Capital first reported a position in Phibro Animal Health in Q4 2018 and has held it in 14 quarters since.
  • Lindbrook Capital's Phibro Animal Health position peaked at $10K in Q2 2020.
  • 182 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.